{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:36Z","timestamp":1786997916885,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.urolonc.2024.05.006","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T15:55:30Z","timestamp":1716566130000},"page":"289.e13-289.e21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Early experience with sequential intravesical gemcitabine and docetaxel for micropapillary variant non-muscle invasive bladder cancer"],"prefix":"10.1016","volume":"42","author":[{"given":"Mohamad","family":"Abou Chakra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"McElree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh T.","family":"Packiam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Mott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.urolonc.2024.05.006_bib0001","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder Cancer: A Review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.urolonc.2024.05.006_bib0002","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO Guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2024.05.006_bib0003","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/JU.0000000000001305","article-title":"A systematic review and meta-analysis of variant histology in urothelial carcinoma of the bladder treated with radical cystectomy","volume":"204","author":"Mori","year":"2020","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2024.05.006_bib0004","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.eururo.2018.11.052","article-title":"Micropapillary urothelial carcinoma of the bladder: a systematic review and meta-analysis of disease characteristics and treatment outcomes","volume":"75","author":"Abufaraj","year":"2019","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2024.05.006_bib0005","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.euf.2021.07.015","article-title":"Survival outcomes after immediate radical cystectomy versus conservative management with Bacillus Calmette-Gu\u00e9rin among T1 high-grade micropapillary bladder cancer patients: results from a multicentre collaboration","volume":"8","author":"Lonati","year":"2022","journal-title":"Eur Urol Focus"},{"issue":"6","key":"10.1016\/j.urolonc.2024.05.006_bib0006","doi-asserted-by":"crossref","first-page":"275.e1","DOI":"10.1016\/j.urolonc.2022.02.004","article-title":"Histological variants of non-muscle invasive bladder cancer: Survival outcomes of radical cystectomy vs. bladder preservation therapy","volume":"40","author":"Dursun","year":"2022","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2024.05.006_bib0007","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3233\/BLC-160066","article-title":"Micropapillary bladder cancer: insights from the national cancer database","volume":"2","author":"Sui","year":"2016","journal-title":"Bladder Cancer"},{"issue":"3","key":"10.1016\/j.urolonc.2024.05.006_bib0008","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.juro.2014.02.2565","article-title":"Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder","volume":"192","author":"Spaliviero","year":"2014","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2024.05.006_bib0009","doi-asserted-by":"crossref","first-page":"336","DOI":"10.7150\/jca.6215","article-title":"Low grade micropapillary urothelial carcinoma, does it exist? - Analysis of management and outcomes from the surveillance, epidemiology and end results (SEER) database","volume":"4","author":"Vourganti","year":"2013","journal-title":"J Cancer"},{"issue":"2","key":"10.1016\/j.urolonc.2024.05.006_bib0010","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.4081\/rt.2011.e22","article-title":"Is radical cystectomy mandatory in every patient with variant histology of bladder cancer","volume":"3","author":"Shapur","year":"2011","journal-title":"Rare Tumors"},{"issue":"5","key":"10.1016\/j.urolonc.2024.05.006_bib0011","first-page":"5370","article-title":"The case for conservative management in the treatment of patients with non-muscle-invasive micropapillary bladder carcinoma without carcinoma in situ","volume":"17","author":"Gaya","year":"2010","journal-title":"Can J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2024.05.006_bib0012","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.juro.2014.09.092","article-title":"Clinical outcomes of cT1 micropapillary bladder cancer","volume":"193","author":"Willis","year":"2015","journal-title":"J Urol"},{"issue":"3 Pt 1","key":"10.1016\/j.urolonc.2024.05.006_bib0013","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0022-5347(05)00423-4","article-title":"The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma [published correction appears in J Urol. 2006 May;175(5):1967]","volume":"175","author":"Kamat","year":"2006","journal-title":"J Urol."},{"issue":"1","key":"10.1016\/j.urolonc.2024.05.006_bib0014","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000375411","article-title":"Is immediate radical cystectomy necessary for all patients with non-muscle-invasive micropapillary bladder cancer?","volume":"96","author":"Jackson","year":"2016","journal-title":"Urol Int"},{"issue":"2","key":"10.1016\/j.urolonc.2024.05.006_bib0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.0849","article-title":"Comparison of sequential intravesical gemcitabine and docetaxel vs Bacillus Calmette-Gu\u00e9rin for the treatment of patients with high-risk non-muscle-invasive bladder cancer","volume":"6","author":"McElree","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.urolonc.2024.05.006_bib0016","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/JU.0000000000002848","article-title":"Sequential intravesical valrubicin and docetaxel for the salvage treatment of non-muscle-invasive bladder cancer","volume":"208","author":"McElree","year":"2022","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.05.006_bib0017","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2559.2004.01895.x","article-title":"Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study","volume":"45","author":"Samaratunga","year":"2004","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.urolonc.2024.05.006_bib0018","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3233\/BLC-150008","article-title":"Sequential intravesical gemcitabine and docetaxel for the salvage treatment of non-muscle invasive bladder cancer","volume":"1","author":"Steinberg","year":"2015","journal-title":"Bladder Cancer"},{"issue":"11","key":"10.1016\/j.urolonc.2024.05.006_bib0019","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1442-2042.2012.03089.x","article-title":"Role of routine transurethral biopsy and isolated upper tract cytology after intravesical treatment of high-grade non-muscle invasive bladder cancer","volume":"19","author":"Lightfoot","year":"2012","journal-title":"Int J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2024.05.006_bib0020","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.eururo.2016.02.056","article-title":"Gene expression profile of the clinically aggressive micropapillary variant of bladder cancer","volume":"70","author":"Guo","year":"2016","journal-title":"Eur Urol"},{"issue":"24","key":"10.1016\/j.urolonc.2024.05.006_bib0021","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1200\/JCO.2005.01.598","article-title":"Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival","volume":"23","author":"Leibovici","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924004642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924004642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T22:13:58Z","timestamp":1718835238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924004642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1078143924004642"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.05.006","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early experience with sequential intravesical gemcitabine and docetaxel for micropapillary variant non-muscle invasive bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}